{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:56:49Z","timestamp":1776164209526,"version":"3.50.1"},"reference-count":44,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Neurotherapeutics"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1586\/14737175.7.6.617","type":"journal-article","created":{"date-parts":[[2007,6,11]],"date-time":"2007-06-11T14:52:51Z","timestamp":1181573571000},"page":"617-626","source":"Crossref","is-referenced-by-count":24,"title":["Oxcarbazepine in the treatment of bipolar and schizoaffective disorders"],"prefix":"10.1586","volume":"7","author":[{"given":"Ekaterine","family":"Popova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Leighton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Bernabarre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miquel","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1055\/s-2001-18036","volume":"34","author":"Dietrich","year":"2001","journal-title":"Pharmacopsychiatry"},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2165\/00044011-200323100-00006","volume":"23","author":"Reinstein","year":"2003","journal-title":"Clin. Drug Invest."},{"key":"CIT0003","first-page":"159","volume":"1","author":"Vieta","year":"2004","journal-title":"Clin. Neuropsychiatry"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4088\/JCP.v64n0301","volume":"64","author":"White","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2004.07.004"},{"key":"CIT0006","first-page":"177","volume":"29","author":"Navarro","year":"2002","journal-title":"Rev. Psiquiatr\u00eda Fac. Med. Barna."},{"key":"CIT0007","unstructured":"Mueller AA, Stoll KD. Carbamazepine and oxcarbamazepine in the treatment of manic syndromes: studies in Germany. In:Anticonvulsats in Affective Disorders. Int. Cong. Series No 626.Emrich HM, Okuma T, Muller AA (Eds). Excerpta Medica, Amsterdam, The Netherlands 139\u2013147 (1984)."},{"key":"CIT0008","unstructured":"Emrich HM, Dose M, Von Zerssen D. Action of sodium-valproate and of oxcarbazepine in patients with affective disorder. In:Anticonvulsants in Affective Disorders.Emrich HM, Okuma T, Mueller AA (Eds), Elsevier Science Publishers BV, Amsterdam, The Netherlands (1984)."},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0091-3057(83)90067-9","volume":"19","author":"Emrich","year":"1983","journal-title":"Pharmacol. Biochem. Behav."},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.7.1179"},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1176\/ajp.2006.163.7.1129","volume":"163","author":"Leibenluft","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199004000-00002"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0165-0327(85)90022-9","volume":"8","author":"Emrich","year":"1985","journal-title":"J. Affect. Disord."},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1586\/14737175.5.1.63","volume":"5","author":"Vieta","year":"2005","journal-title":"Expert Rev. Neurother."},{"key":"CIT0015","unstructured":"Mu\u00f1oz RA. Oxcarbamazepine for the treatment of bipolar disorder. Presented at:The 5th International Conference on Bipolar Disorder.Pittsburgh, USA, 12\u201314 June 2003."},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(02)00407-X"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000195911.13870.f3"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2002.02228.x"},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1017\/S1461145703003754","volume":"6","author":"Raja","year":"2003","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2003.00047.x"},{"key":"CIT0021","first-page":"56","volume":"11","author":"Benabarre","year":"2004","journal-title":"Psiquiatr\u00eda Biol\u00f3gica"},{"key":"CIT0022","unstructured":"Comes M, Vieta E, Benabarre A, Goikolea JM, Corbella B, Colom F. Oxcarbazepine for hipomania in bipolar II disorder. Presented at:The 5th International Conference on Bipolar Disorder.PA, USA, 12\u201314 June 2003."},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1055\/s-2007-1017235","volume":"19","author":"Cabrera","year":"1986","journal-title":"Pharmacopsychiatry"},{"key":"CIT0024","unstructured":"Berv DA, Klugman J, Hsu DJ, Rosenquist KJ, Ghaemi SN. Prophylactic efficacy of oxcarbazepine in bipolar disorder. Presented at:The 5th International Conference on Bipolar Disorder.PA, USA, 12\u201314 June 2003."},{"key":"CIT0025","unstructured":"Deutschman DA, Deutschman DH, Chalakian JS. Oxcarbazepine efficacy\/safety in bipolar disorder: a retrospective review of 249 patients. Presented at:The 5th International Conference on Bipolar Disorder.PA, USA, 12\u201314 June 2003."},{"key":"CIT0026","unstructured":"Vieta E, Comes M, Garc\u00eda-Campayo Jet al.A double-blind, placebo-controlled, randomized prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder. Presented at:The Fifth European Stanley Conference on Bipolar Disorder.Barcelona, Spain, 5\u20137 October 2006."},{"key":"CIT0027","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/00004583-200109000-00005","volume":"40","author":"Teitelbaum","year":"2001","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"CIT0028","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1176\/appi.ajp.159.10.1793","volume":"159","author":"Nasr","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D442"},{"key":"CIT0030","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1034\/j.1399-5618.2002.40104.x","volume":"4","author":"Ghaemi","year":"2002","journal-title":"Bipolar Disord."},{"key":"CIT0031","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4088\/JCP.v64n0813","volume":"64","author":"Ghaemi","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"CIT0032","unstructured":"Platt DE, Munasifi FA, McKay LM. Retrospective chart review on the use of oxcarbazepine in patients with bipolar disorder. Presented at:The 5th International Conference on Bipolar Disorder.PA, USA, June 12\u201314 2003."},{"key":"CIT0033","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1111\/j.1399-5618.2005.00253.x","volume":"7","author":"Pratoomsri","year":"2005","journal-title":"Bipolar Disord."},{"key":"CIT0034","unstructured":"Schaffer CB, Schaffer LC, Howe JL. The use of oxcarbazepine in refractory bipolar outpatients. Presented at:The 5th International Conference on Bipolar Disorder.Pittsburgh, USA, June 12\u201314 (2003)."},{"key":"CIT0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0920-1211(02)00080-3","volume":"50","author":"Muzina","year":"2002","journal-title":"Epilepsy Res."},{"key":"CIT0036","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1528-1167.2005.463008.x","volume":"46","author":"Gajwani","year":"2005","journal-title":"Epilepsia"},{"key":"CIT0037","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S0165-0327(02)00338-5","volume":"72","author":"Hellewell","year":"2002","journal-title":"J. Affect. Disord."},{"key":"CIT0038","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1525-5050(02)00017-3","volume":"3","author":"Beydoun","year":"2002","journal-title":"Epilepsy Behav."},{"key":"CIT0039","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1528-1157.1987.tb03702.x","volume":"28","author":"Houtkooper","year":"1987","journal-title":"Epilepsia"},{"key":"CIT0040","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1528-1167.2005.71104.x","volume":"46","author":"Muscatello","year":"2005","journal-title":"Epilepsia"},{"key":"CIT0041","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/070674370605100809","volume":"5","author":"Pratoomsri","year":"2006","journal-title":"Can. J. Psychiatry"},{"key":"CIT0042","first-page":"S89","volume":"5","author":"Wildgrube","year":"1990","journal-title":"Int. Clin. Psychopharmacol."},{"key":"CIT0043","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00131746-200607000-00003","volume":"12","author":"Macmillan","year":"2006","journal-title":"J. Psychiatr. Pract."},{"key":"CIT0044","unstructured":"Velikonja M, Heinrich K. Effect of oxcarbazepine (GP 47 680) on affective and shizoaffective symptoms: a preliminary report. In:Anticonvulsants in Affective Disorders.Emrich HM, Okuma T, Mueller AA (Eds). Elsevier Science Publishers BV, Amsterdam, The Netherlands (1984)."}],"container-title":["Expert Review of Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14737175.7.6.617","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T01:18:29Z","timestamp":1556500709000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14737175.7.6.617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,1,10]]},"published-print":{"date-parts":[[2007,6]]}},"alternative-id":["10.1586\/14737175.7.6.617"],"URL":"https:\/\/doi.org\/10.1586\/14737175.7.6.617","relation":{},"ISSN":["1473-7175","1744-8360"],"issn-type":[{"value":"1473-7175","type":"print"},{"value":"1744-8360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}